切换至 "中华医学电子期刊资源库"

中华乳腺病杂志(电子版) ›› 2015, Vol. 09 ›› Issue (06) : 372 -375. doi: 10.3877/cma. j. issn.1674-0807.2015.06.005

论著

高表达twist 基因促进三阴性乳腺癌SUM159 细胞干性特征的初步研究
曾真1, 甘霖1, 王亚冬1, 闵捷1, 王婷1, 廖登辉1, 吕钢1,()   
  1. 1.400011 重庆市第一中医院乳腺甲状腺科
  • 收稿日期:2015-06-15 出版日期:2015-12-01
  • 通信作者: 吕钢
  • 基金资助:
    2014 年重庆市科学技术委员会前沿与应用基础研究项目(cstc2014jcyjA83)

Preliminary study on high expression of twist gene promoting the stemness related characteristics of triple negative breast cancer SUM159 cells

Zhen Zeng1, Lin Gan1, Yadong Wang1, Jie Min1, Ting Wang1, Denghui Liao1, Gang Lyu1,()   

  1. 1.Department of Breast and Thyroid Surgery, the First Hospital of Traditional Chinese Medicine of Chongqing Municipality, Chongqing 400011, China
  • Received:2015-06-15 Published:2015-12-01
  • Corresponding author: Gang Lyu
引用本文:

曾真, 甘霖, 王亚冬, 闵捷, 王婷, 廖登辉, 吕钢. 高表达twist 基因促进三阴性乳腺癌SUM159 细胞干性特征的初步研究[J/OL]. 中华乳腺病杂志(电子版), 2015, 09(06): 372-375.

Zhen Zeng, Lin Gan, Yadong Wang, Jie Min, Ting Wang, Denghui Liao, Gang Lyu. Preliminary study on high expression of twist gene promoting the stemness related characteristics of triple negative breast cancer SUM159 cells[J/OL]. Chinese Journal of Breast Disease(Electronic Edition), 2015, 09(06): 372-375.

目的

探讨高表达twist 基因对乳腺癌SUM159 细胞干性特征的影响。

方法

用慢病毒构建过表达twist 基因的乳腺癌SUM159 细胞作为实验组(SUM159/twist),空载体构建对照组细胞(SUM159/vector)。 利用RT-PCR 检测twist 转染前后mRNA 水平变化;通过平板克隆形成、成球实验、流式细胞仪检测肿瘤干细胞比例,并用RT-PCR 检测干性相关基因SOX2、OCT4、BMI1 的mRNA 表达水平。mRNA 及细胞克隆数等计量资料以¯x±s 表示,组间比较采用t 检验。

结果

成功构建过表达twist 基因的乳腺癌SUM159 细胞,SUM159/twist 细胞中的twist mRNA 表达为2.04±0.15,高于SUM159/vector 细胞的0.49±0.45(t=-16.33,P <0.001);SUM159/twist 细胞的克隆菌落数目(92.75±4.85)明显高于SUM159/vector 细胞(44.50±5.19)(t=13.56,P<0.001);成球实验显示:SUM159/twist 细胞形成的细胞球数目(46.75±4.11)显著高于SUM159/vector 细胞(22.50±3.41)(t=9.07,P<0.001);利用流式细胞仪检测SUM159/twist 和SUM159/vector 细胞中的ALDH1+细胞比例发现:SUM159/twist 细胞中ALDH1+细胞比例为(9.63±0.89)%,显著高于SUM159/vector 细胞中的(2.31±0.21)%(t=13.85,P<0.001);SUM159/twist 细胞中SOX2、OCT4、BMI1 的表达(12.39±0.63、13.35±1.56、6.48±0.96)均高于SUM159/vector 细胞(1.61±0.33、2.67±0.28、2.70±0.35)(t=-29.68,-11.61,6.43;P 均<0.001)。

结论

twist 基因能够增强乳腺癌SUM159 细胞干性能力。

Objective

To investigate the impact of high expression of twist gene on the stemness related characteristics of breast cancer SUM159 cells.

Methods

We established a twist-overexpression breast cancer SUM159 cell line as experimental group (SUM159/twist), and the cells with blank vector construction served as control group (SUM159/vector). The twist mRNA level were detected before and after twist gene transfection using RT-PCR. The proportion of cancer stem cells was investigated by flat clone formation,mammosphere assay and flow cytometry. The mRNA expressions of stemness-related genes SOX2, OCT4 and BMI1 were detected by RT-PCR. All data were expressed as ¯x±s and processed by t test.

Results

SUM159 cells with twist gene overexpression were successfully established. The relative expression of twist mRNA in SUM159/twist cells was 2.04±0.15, significantly higher than 0.49±0.45 in SUM159/vector cells(t=-16.33,P<0.001).The colony number of clone formation was 92.75±4.85 in SUM159/twist cells, significantly higher than 44.50±5.19 in SUM159/vector cells(t=13.56, P<0.001).The mammosphere number was 46.75±4.11 in SUM159/twist cells and 22.50±3.41 in SUM159/vector cells, and the difference was statistically significant(t=9.07, P<0.001). Flow cytometry results showed that the proportion of ALDH1+ was (9.63±0.89)% in SUM159/twist cells and (2.31±0.21)% in SUM159/vector cells, indicating a significant difference(t =13.85, P<0.001). The relative mRNA expressions of SOX2, OCT4 and BMI1 in SUM159/twist cells were 12.39±0.63,13.35±1.56 and 6.48±0.96, significantly higher than 1.61±0.33,2.67±0.28 and 2.70±0.35 in SUM159/vector cells respectively(t=-29.68,-11.61,6.43,all P<0.001).

Conclusion

The twist gene promotes the stemness related capability of breast cancer SUM159 cells.

图1 twist 基因过表达后对乳腺癌SUM159 细胞克隆形成能力的影响
图2 twist 基因过表达后对乳腺癌SUM159 细胞成球能力的影响
图3 twist 基因过表达后对乳腺癌SUM159 细胞中ALDH1+细胞比例影响的流式细胞图 注:SSC-H 代表侧向散射角
[1]
Siegel RL, Miller KD, Jemal A. Cancer statistics,2015[J].CA Cancer J Clin,2015,65(1):5-29.
[2]
Liu R, Wang X,Chen GY,et al. The prognostic role of a gene signature from tumorigenic breast-cancer cells[J]. N Engl J Med,2007,356(3):217-226.
[3]
Xu Y, Hu B, Qin L, et al. SRC-1 and Twist1 expression positively correlates with a poor prognosis in human breast cancer[J]. Int J Biol Sci,2014,10(4):396-403.
[4]
Fang X, Cai Y, Liu J, et al. Twist2 contributes to breast cancer progression by promoting an epithelial-mesenchymal transition and cancer stem-like cell self-renewal [J].Oncogene,2011,30 (47):4707-4720.
[5]
Yang J,Mani SA,Donaher JL,et al. Twist,a master regulator of morphogenesis, plays an essential role in tumor metastasis[J]. Cell,2004,117(7):927-939.
[6]
Ai L, Kim WJ, Alpay M, et al. TRIM29 suppresses TWIST1 and invasive breast cancer behavior[J]. Cancer Res, 2014,74(17):4875-4887.
[7]
Clarke MF, Dick JE, Dirks PB, et al. Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells [J]. Cancer Res, 2006,66(19):9339-9344.
[8]
Ginestier C, Hur MH, Charafe-Jauffret E, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome[J]. Cell Stem Cell,2007,1(5):555-567.
[9]
Jin F, Zhao L, Zhao HY,et al. Comparison between cells and cancer stem-like cells isolated from glioblastoma and astrocytoma on expression of anti-apoptotic and multidrug resistance-associated protein genes[J]. Neuroscience, 2008,154(2):541-550.
[10]
Bora-Singhal N, Perumal D, Nguyen J, et al. Gli1-mediated regulation of Sox2 facilitates self-renewal of stem-like cells and confers resistance to EGFR inhibitors in non-small cell lung cancer[J]. Neoplasia,2015,17(7):538-551.
[11]
Lee CJ, Dosch J, Simeone DM. Pancreatic cancer stem cells[J]. J Clin Oncol,2008,26(17):2806-2812.
[12]
Liu AY, Cai Y, Mao Y, et al. Twist2 promotes self-renewal of liver cancer stem-like cells by regulating CD24 [J].Carcinogenesis,2014,35(3):537-545.
[1] 李洋, 蔡金玉, 党晓智, 常婉英, 巨艳, 高毅, 宋宏萍. 基于深度学习的乳腺超声应变弹性图像生成模型的应用研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 563-570.
[2] 周荷妹, 金杰, 叶建东, 夏之一, 王进进, 丁宁. 罕见成人肋骨郎格汉斯细胞组织细胞增生症被误诊为乳腺癌术后骨转移一例[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 380-383.
[3] 河北省抗癌协会乳腺癌专业委员会护理协作组. 乳腺癌中心静脉通路护理管理专家共识[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 321-329.
[4] 刘晨鹭, 刘洁, 张帆, 严彩英, 陈倩, 陈双庆. 增强MRI 影像组学特征生境分析在预测乳腺癌HER-2 表达状态中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 339-345.
[5] 张晓宇, 殷雨来, 张银旭. 阿帕替尼联合新辅助化疗对三阴性乳腺癌的疗效及预后分析[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 346-352.
[6] 邱琳, 刘锦辉, 组木热提·吐尔洪, 马悦心, 冷晓玲. 超声影像组学对致密型乳腺背景中非肿块型乳腺癌的诊断价值[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 353-360.
[7] 程燕妮, 樊菁, 肖瑶, 舒瑞, 明昊, 党晓智, 宋宏萍. 乳腺组织定位标记夹的应用与进展[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 361-365.
[8] 涂盛楠, 胡芬, 张娟, 蔡海峰, 杨俊泉. 天然植物提取物在乳腺癌治疗中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 366-370.
[9] 朱文婷, 顾鹏, 孙星. 非酒精性脂肪性肝病对乳腺癌发生发展及治疗的影响[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 371-375.
[10] 葛睿, 陈飞, 李杰, 李娟娟, 陈涵. 多基因检测在早期乳腺癌辅助治疗中的应用价值[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(05): 257-263.
[11] 韩萌萌, 冯雪园, 马宁. 乳腺癌改良根治术后桡神经损伤1例[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 117-118.
[12] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[13] 张志兆, 王睿, 郜苹苹, 王成方, 王成, 齐晓伟. DNMT3B与乳腺癌预后的关系及其生物学机制[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 624-629.
[14] 王玲艳, 高春晖, 冯雪园, 崔鑫淼, 刘欢, 赵文明, 张金库. 循环肿瘤细胞在乳腺癌新辅助及术后辅助治疗中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 630-633.
[15] 赵林娟, 吕婕, 王文胜, 马德茂, 侯涛. 超声引导下染色剂标记切缘的梭柱型和圆柱型保乳区段切除术的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 634-637.
阅读次数
全文


摘要